News: Professor Christopher Sweeney

Developing the first drug for multi-organ radiation protection

A pharmaceutical breakthrough at 91ΧΤΕΔ is showing promise in both multi-organ radiation protection and cancer treatment.

[Read more about Developing the first drug for multi-organ radiation protection]